Author : Huyvanyuk O.A.
Clinical characteristics, treatment characteristics, and endpoints assessed in real-world clinical practice of talazoparib in patients with HER2-negative BRCA-associated breast cancer
|
|
|
|
|
Author : Huyvanyuk O.A. |
|